Diabetes Mellitus, Type 2

"Diabetes Mellitus, Type 2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.

Descriptor ID	D003924
MeSH Number(s)	C18.452.394.750.149 C19.246.300
Concept/Terms	Diabetes Mellitus, Type 2 Diabetes Mellitus, Type 2 Diabetes Mellitus, Noninsulin-Dependent Diabetes Mellitus, Ketosis-Resistant Diabetes Mellitus, Ketosis Resistant Ketosis-Resistant Diabetes Mellitus Diabetes Mellitus, Non Insulin Dependent Diabetes Mellitus, Non-Insulin-Dependent Non-Insulin-Dependent Diabetes Mellitus Diabetes Mellitus, Stable Stable Diabetes Mellitus Diabetes Mellitus, Type II NIDDM Diabetes Mellitus, Noninsulin Dependent Diabetes Mellitus, Maturity-Onset Diabetes Mellitus, Maturity Onset Maturity-Onset Diabetes Mellitus Maturity Onset Diabetes Mellitus MODY Diabetes Mellitus, Slow-Onset Diabetes Mellitus, Slow Onset Slow-Onset Diabetes Mellitus Type 2 Diabetes Mellitus Noninsulin-Dependent Diabetes Mellitus Noninsulin Dependent Diabetes Mellitus Maturity-Onset Diabetes Diabetes, Maturity-Onset Maturity Onset Diabetes Type 2 Diabetes Diabetes, Type 2 Diabetes Mellitus, Adult-Onset Adult-Onset Diabetes Mellitus Diabetes Mellitus, Adult Onset

Below are MeSH descriptors whose meaning is more general than "Diabetes Mellitus, Type 2".

Diseases [C]
Nutritional and Metabolic Diseases [C18]
Metabolic Diseases [C18.452]
Glucose Metabolism Disorders [C18.452.394]
Diabetes Mellitus [C18.452.394.750]
Diabetes Mellitus, Type 2 [C18.452.394.750.149]
Endocrine System Diseases [C19]
Diabetes Mellitus [C19.246]
Diabetes Mellitus, Type 2 [C19.246.300]

Below are MeSH descriptors whose meaning is related to "Diabetes Mellitus, Type 2".

Below are MeSH descriptors whose meaning is more specific than "Diabetes Mellitus, Type 2".

Diabetes Mellitus, Type 2
Diabetes Mellitus, Lipoatrophic

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Diabetes Mellitus, Type 2" by people in this website by year, and whether "Diabetes Mellitus, Type 2" was a major or minor topic of these publications.

Bar chart showing 387 publications over 25 distinct years, with a maximum of 32 publications in 2015

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1992	0	1	1
1995	1	0	1
1996	1	0	1
2000	1	1	2
2001	1	1	2
2002	5	0	5
2003	10	0	10
2004	6	2	8
2005	18	6	24
2006	13	2	15
2007	11	3	14
2008	11	2	13
2009	14	6	20
2010	20	1	21
2011	22	1	23
2012	21	3	24
2013	17	6	23
2014	24	3	27
2015	29	3	32
2016	24	6	30
2017	20	3	23
2018	15	1	16
2019	21	3	24
2020	12	1	13
2021	13	2	15

Below are the most recent publications written about "Diabetes Mellitus, Type 2" by people in Profiles.

Poon IO, Ogboe CW. Applying the Social-Ecological Approach to Evaluate Diabetes Medication Management in Older People. Sr Care Pharm. 2021 Nov 01; 36(11):548-555.

View in: PubMed
Sepehri A, Nepal B, Lazaridis T. Distinct Modes of Action of IAPP Oligomers on Membranes. J Chem Inf Model. 2021 09 27; 61(9):4645-4655.

View in: PubMed
Leak-Johnson T, Yan F, Daniels P. What the Jackson Heart Study Has Taught Us About Diabetes and Cardiovascular Disease in the African American Community: a 20-year Appreciation. Curr Diab Rep. 2021 09 08; 21(10):39.

View in: PubMed
Rubas NC, Maunakea A. Medical School Hotline: Immunoepigenetic-Microbiome Axis: Implications for Health Disparities Research in Native Hawaiians and Pacific Islanders. Hawaii J Health Soc Welf. 2021 08; 80(8):195-198.

View in: PubMed
Haslam DE, Liang L, Wang DD, Kelly RS, Wittenbecher C, Pérez CM, Martínez M, Lee CH, Clish CB, Wong DTW, Parnell LD, Lai CQ, Ordovás JM, Manson JE, Hu FB, Stampfer MJ, Tucker KL, Joshipura KJ, Bhupathiraju SN. Associations of network-derived metabolite clusters with prevalent type 2 diabetes among adults of Puerto Rican descent. BMJ Open Diabetes Res Care. 2021 08; 9(1).

View in: PubMed
Modi A, Gadhavi R, Pérez CM, Joshipura K. Longitudinal association between adiposity measures and regression of prediabetes/diabetes. Nutr Metab Cardiovasc Dis. 2021 10 28; 31(11):3085-3094.

View in: PubMed
Streicher SA, Lim U, Park SL, Li Y, Sheng X, Hom V, Xia L, Pooler L, Shepherd J, Loo LWM, Darst BF, Highland HM, Polfus LM, Bogumil D, Ernst T, Buchthal S, Franke AA, Setiawan VW, Tiirikainen M, Wilkens LR, Haiman CA, Stram DO, Cheng I, Le Marchand L. Genome-wide association study of pancreatic fat: The Multiethnic Cohort Adiposity Phenotype Study. PLoS One. 2021; 16(7):e0249615.

View in: PubMed
Vieira ER, Cavalcanti FADC, Civitella F, Hollifield M, Caceres S, Carreno J, Gaillard T, Huffman FG, Mora JC, Queiroga MR. Effects of Exercise and Diet on Body Composition and Physical Function in Older Hispanics with Type 2 Diabetes. Int J Environ Res Public Health. 2021 07 29; 18(15).

View in: PubMed
Maskarinec G, Raquinio PA, Setiawan VW, Ernst T, Franke AA, Buchthal SD, Shepherd JA, Wilkens LR, Lim U, Le Marchand L. Biomarker-based visceral adiposity score and incident type 2 diabetes in the multiethnic cohort. Ann Epidemiol. 2021 11; 63:29-34.

View in: PubMed
Frias JP, Bonora E, Nevárez Ruiz L, Hsia SH, Jung H, Raha S, Cox DA, Bethel MA, Konig M. Efficacy and safety of dulaglutide 3.0?and 4.5?mg in patients aged?younger than?65 and?65?years or older: Post hoc analysis of the AWARD-11 trial. Diabetes Obes Metab. 2021 10; 23(10):2279-2288.

View in: PubMed

People

Explore

Similar Concepts

Top Journals